IEVA Contribution to Spanish TRIS notification

Industry InsightEvents
Jun.27.2022
IEVA Contribution to Spanish TRIS notification
IEVA calls on the Spanish government, Spanish medical authorities, Spanish autonomous communities, and Spanish consultative bodies that will provide comments on the draft bill to critically reconsider this measure and reject an unfair and disproportionate law that will paradoxically only increase the combustible tobacco/ smoking prevalence rate in Spain.

The Spanish Government has recently launched a draft bill that threatens to end the independent vaping sector in Spain and give the entire electronic cigarette business to big tobacco companies.

 

Against all principles of EU law (proportionality, good regulation, good administration, fair competition and harmonisation), the Spanish Government has proposed in its “Anteproyecto de Ley del Mercado de Tabacos y otros Productos Relacionados” to ban and close all vape shops across Spain (transferring the sale of electronic cigarettes and e-liquids to the state monopoly of tobacco shops (estancos)) and to prohibit all online sales.

 

These measures clearly go against:

  1. Free competition in the EU;
  2. Freedom of movement of goods in the internal market;
  3. Will generate severe unemployment in a moment of emerging economic crisis and
  4. Will have a devastating effect on the fight against smoking in Spain as this will deprive vapers from personalised access to vaping products, forcing them to buy them precisely at a tobacco shop, where the majority of products sold are products they quit with great and continuing efforts (i.e. combustible tobacco).

IEVA calls on the Spanish government, Spanish medical authorities, Spanish autonomous communities, and Spanish consultative bodies that will provide comments on the draft bill to critically reconsider this measure and reject an unfair and disproportionate law that will paradoxically only increase the combustible tobacco/ smoking prevalence rate in Spain.

 

Also read:

ECCC and IEVA successfully held an online exchange meeting

Exclusive Interview With IEVA: EU Tobacco Tax Policy Will Be Landed At The End Of This Year

2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
Germany Expands Take-Back Rules for Disposable Vapes From July 1
Germany Expands Take-Back Rules for Disposable Vapes From July 1
Germany has expanded take-back obligations for disposable vapes from July 1, 2026, requiring consumers to be able to return used devices at stores that sell such products, including kiosks, petrol stations and vape shops, as e-cigarette regulation extends from sales to waste management and lithium-battery safety.
Market
Jul.06 by 2Firsts Perspectives
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28
UK Proposes Stricter Vape Packaging Rules as Retailers Warn of £330 Million Impact
UK Proposes Stricter Vape Packaging Rules as Retailers Warn of £330 Million Impact
The UK government has launched a nationwide consultation on vape packaging, appearance and retail displays, proposing tighter rules to reduce youth appeal while industry groups warn of significant compliance costs.
Innovation
Jul.20